Facilitating Equity & Access for Global Cell and Gene Therapy Patients: How Do We Get There From Here

Join us for a session discussing strategies for achieving equity for cell and gene therapy patients worldwide through better processes, Regulatory Transformation, Market Access and wider collaboration. Learn about current challenges and opportunities in the field, and explore ways to progress towards a more inclusive and equitable future for ATMP patients.

Joined by:

• Miguel Forte, President, International Society for Cell & Gene Therapy & Chief Executive Officer, Kiji Therapeutics
• Boro Dropulic, Executive Director, Caring Cross
• Dorothea Ledergerber, Independent
• Ignacio Nunez, Chief Operating Officer, CellReady
• Tay Salimullah, Chief Access Officer, Novartis Gene Therapies